Fig. 3From: Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trialRepresentative abdominal fat CT data at baseline and 16 weeks in a subject from NAOs or placebo group. NAOs, Neoagaro-oligosaccharides; CT, computed tomography; TFA, total abdominal fat area; VFA, visceral fat area; SFA, subcutaneous fat area; VSR, visceral-subcutaneous fat area ratioBack to article page